Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 21 January 2025 - 17:09

Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 5, Status: Authorised

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 January 2025, 10:00 (CET) to 22 January 2025, 12:30 (CET)

Submitted by Anonymous (not verified) on 21 January 2025 - 15:10

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 January 2025, 10:00 (CET) to 22 January 2025, 12:30 (CET)

Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use

Submitted by Anonymous (not verified) on 21 January 2025 - 12:53

Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness